Sponsor Check › Person
Related person on Form D filings · address states/countries as listed: MD, CA, Israel (as filed: L3), NJ · listed Nov 27, 2009 → Sep 11, 2019
Data last updated: Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 23, 2026, 11:56 PM ET · SEC enforcement last checked: not yet
Privacy: business-related public information only. Residential addresses are never shown; only the state from the filing.
The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.
None found in sources searched.
Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30) — federal district + bankruptcy courts; live RECAP re-check pending. State courts: not yet searched. PACER: not searched. · Last checked Oct 23, 2026, 11:56 PM ET.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched; State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.
Not yet searched.
Search queued. Results are added automatically; check back later or follow this page to be notified.
None found in sources searched.
Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Last checked Oct 23, 2026, 11:56 PM ET.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
Comparisons are made for sponsors and sponsor groups, not individual people.
6 of 36 offerings report sales commissions totalling $4,812,270; 1 reports finder's fees totalling $140,000; 11 report proceeds to related persons totalling $3,197,142. (includes amounts the issuer reported as estimates)
| Source | Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it |
|---|---|---|---|---|---|
| EDGAR ↗ | May 8, 2024 D File 021-512729 | $0 | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Feb 28, 2020 D File 021-361680 | $1,500,000 (est.) | $0 | $0 (est.) | Andrew Garrett, Inc. BrokerCheck CRD 29931 ↗ |
| EDGAR ↗ | Sep 11, 2019 D File 021-348514 | $0 | $0 | $0 (est.) The amount above is an estimate as an unknown portion of the proceeds may be used for payment to the Chief Executive Officer of the Company. | None listed on this filing |
| EDGAR ↗ | Jan 17, 2019 D File 021-330812 | $0 (est.) | $0 (est.) | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Jan 10, 2019 D File 021-330172 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Oct 2, 2018 D File 021-322648 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 11, 2017 D File 021-300453 | $55,250 (est.) | $0 | $0 | Andrew Garrett, Inc. BrokerCheck CRD 29931 ↗ |
| EDGAR ↗ | Jul 17, 2017 D File 021-290913 | $0 | $0 | $5,000 (est.) $5,000 per month to be paid to Mr. D'Agostino as salary. | None listed on this filing |
| EDGAR ↗ | Jun 28, 2017 D/A File 021-261550 | $1,430,494 | $0 | $0 | Andrew Garrett, Inc. BrokerCheck CRD 29931 ↗ |
| EDGAR ↗ | Oct 19, 2016 D File 021-272814 | $0 | $0 | $5,000 (est.) $5,000.00 per month to be paid to Mr. D'Agostino as salary starting September 30, 2016. | None listed on this filing |
| EDGAR ↗ | Jun 24, 2016 D File 021-265718 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 12, 2015 D/A File 021-223836 | $0 | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Mar 12, 2015 D File 021-235727 | $0 | $0 | $500,000 (est.) | None listed on this filing |
| EDGAR ↗ | Dec 8, 2014 D File 021-229642 | $0 | $0 | $0 (est.) Proceeds will be used for, among other things, general corporate purposes including, but not limited to, executive salaries | None listed on this filing |
| EDGAR ↗ | Sep 12, 2014 D File 021-224612 | $394,680 (est.) | $0 | $0 | Andrew Garrett, Inc. BrokerCheck CRD 29931 ↗ |
| EDGAR ↗ | Feb 21, 2014 D File 021-212314 | $0 | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Jan 3, 2014 D File 021-209183 | $0 | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Dec 16, 2013 D/A File 021-188326 | $0 | $0 | $0 (est.) Proceeds will be used for, among other things, general corporate purposes including, but not limited to, executive salaries | None listed on this filing |
| EDGAR ↗ | Oct 2, 2013 D File 021-203875 | $0 | $0 | $100,000 (est.) | None listed on this filing |
| EDGAR ↗ | Aug 20, 2013 D/A File 021-194884 | $0 | $0 | $272,500 (est.) | None listed on this filing |
| EDGAR ↗ | Jun 4, 2013 D/A File 021-195730 | $0 | $0 | $229,642 (est.) | None listed on this filing |
| EDGAR ↗ | Mar 28, 2013 D/A File 021-187761 | $969,202 (est.) | $0 | $0 (est.) A portion of the proceeds will be used for general corporate purposes, which includes the payment of salaries to the executive officers named in the response to Item 3. | Andrew Garrett, Inc. BrokerCheck CRD 29931 ↗ |
| EDGAR ↗ | Dec 13, 2012 D File 021-188345 | $0 | $0 | $100,000 (est.) | None listed on this filing |
| EDGAR ↗ | Nov 9, 2012 D File 021-186778 | $0 | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Jun 21, 2012 D File 021-180116 | $0 | $0 | $800,000 (est.) | None listed on this filing |
| EDGAR ↗ | Dec 14, 2011 D File 021-170051 | $0 | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Jul 15, 2011 D/A File 021-149681 | $0 | $0 | $725,000 (est.) | None listed on this filing |
| EDGAR ↗ | Jun 9, 2011 D File 021-161042 | $0 | $140,000 (est.) | $0 (est.) | M.M. Dillon & Co. LLC BrokerCheck CRD 19878 ↗ via Jeff Swarz (CRD 1563420 ↗) |
| EDGAR ↗ | May 27, 2011 D File 021-160446 | $0 | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Jan 20, 2011 D File 021-154112 | $0 | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Jan 13, 2011 D File 021-153682 | $0 | $0 | $100,000 (est.) | None listed on this filing |
| EDGAR ↗ | Dec 27, 2010 D File 021-152515 | $462,644 (est.) | $0 | $360,000 (est.) The Offering Memorandum provides that a portion of the proceeds will be allocated to working capital. The Company estimates a portion of the working capital will fund modest salaries for officers; no amounts will be paid to directors or promoters. | Andrew Garrett, Inc. BrokerCheck CRD 29931 ↗ |
| EDGAR ↗ | Dec 10, 2010 D/A File 021-137660 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 16, 2010 D/A File 021-102229 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 16, 2010 D File 021-139631 | $0 | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Jul 13, 2009 D File 021-92160 | $0 | $0 | $0 | None listed on this filing |
As reported by the issuer on Form D (Items 12–15), latest filing per offering (one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across every filing this person is listed on (latest filing per offering, per issuer).
| Source | Issuer | Role | Filed | Form | Offering | Sold | Investors | Min. investment |
|---|---|---|---|---|---|---|---|---|
| EDGAR ↗ | GlucoTrack, Inc. | Director | May 8, 2024 | D | $500,000 similar: $2,000,000–$19,999,994 | $500,000 | 9 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | GlucoTrack, Inc. | Director | Feb 28, 2020 | D | $15,000,000 similar: $2,000,000–$19,999,994 | $15,000,000 | 1 similar: 2–16 | $1 similar: $10,000–$50,000 |
| EDGAR ↗ | Zygood,LLC group: Magnemark | Executive Officer, Director Manager; Chairman and Chief Technology Officer. | Sep 11, 2019 | D | $250,000 similar: $829,831–$9,999,998 | $100,000 | 1 similar: 2–15 | $1,000 similar: $10,000–$54,310 |
| EDGAR ↗ | Avertix Medical, Inc. | Director | Jan 17, 2019 | D | $2,500,000 similar: $829,831–$9,999,998 | $600,000 | 2 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Zygood,LLC group: Magnemark | Executive Officer Manager; Chairman and Chief Technology Officer. | Jan 10, 2019 | D | $300,000 similar: $829,831–$9,999,998 | $29,210 | 6 similar: 2–15 | $3,333 similar: $10,000–$54,310 |
| EDGAR ↗ | Zygood,LLC group: Magnemark | Executive Officer, Director Manager; Chairman and Chief Technology Officer. | Oct 2, 2018 | D | $138,878 similar: $829,831–$9,999,998 | $138,878 | 4 similar: 2–15 | $10,214 similar: $10,000–$54,310 |
| EDGAR ↗ | GlucoTrack, Inc. | Director | Dec 11, 2017 | D | $10,000,000 similar: $829,831–$9,999,998 | $425,000 | 6 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Zygood,LLC group: Magnemark | Executive Officer Manager; Chairman and Chief Executive Officer. | Jul 17, 2017 | D | $200,000 similar: $829,831–$9,999,998 | $184,000 | 4 similar: 2–15 | $3,333 similar: $10,000–$54,310 |
| EDGAR ↗ | GlucoTrack, Inc. | Director | Jun 28, 2017 | D/A | $12,000,000 similar: $829,831–$9,999,998 | $11,003,800 | 96 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | GlucoTrack, Inc. | Director | Jan 20, 2017 | D/A | $12,000,000 similar: $829,831–$9,999,998 | $6,232,800 | 78 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Zygood,LLC group: Magnemark | Executive Officer Manager; Chairman and Chief Executive Officer. | Oct 19, 2016 | D | $194,000 similar: $829,831–$9,999,998 | $194,000 | 15 similar: 2–15 | $1,000 similar: $10,000–$54,310 |
| EDGAR ↗ | Zygood,LLC group: Magnemark | Executive Officer Manager; Chairman and Chief Executive Officer. | Jun 24, 2016 | D | $58,200 similar: $829,831–$9,999,998 | $58,200 | 16 similar: 2–15 | $300 similar: $10,000–$54,310 |
| EDGAR ↗ | GlucoTrack, Inc. | Director | Apr 18, 2016 | D | $12,000,000 similar: $829,831–$9,999,998 | $1,133,000 | 17 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | eNeura, INC. | Executive Officer, Director | Mar 12, 2015 | D/A | $31,117,692 similar: $1,100,015–$10,001,163 | $5,826,421 | 70 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | eNeura, INC. | Executive Officer, Director | Mar 12, 2015 | D | $15,000,000 similar: $1,100,015–$10,001,163 | $15,000,000 | 1 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | Avertix Medical, Inc. | Director | Dec 8, 2014 | D | $20,500,000 similar: $829,831–$9,999,998 | $10,215,000 | 22 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | GlucoTrack, Inc. | Director | Sep 12, 2014 | D | $8,500,000 similar: $829,831–$9,999,998 | $3,036,000 | 31 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | eNeura, INC. | Executive Officer, Director | Aug 29, 2014 | D | $6,589,156 similar: $1,100,015–$10,001,163 | $5,776,211 | 67 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | eNeura, INC. | Executive Officer, Director | Feb 21, 2014 | D | $2,500,000 similar: $1,100,015–$10,001,163 | $1,674,000 | 15 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | eNeura, INC. | Executive Officer, Director | Jan 3, 2014 | D | $2,212,035 similar: $1,100,015–$10,001,163 | $2,212,035 | 1 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | Avertix Medical, Inc. | Director | Dec 16, 2013 | D/A | $20,546,000 similar: $829,831–$9,999,998 | $20,531,000 | 23 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | eNeura, INC. | Executive Officer, Director | Oct 2, 2013 | D | $1,500,000 similar: $1,100,015–$10,001,163 | $589,990 | 9 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | eNeura, INC. | Executive Officer, Director | Aug 20, 2013 | D/A | $3,225,000 | $3,224,999 | 49 | No minimum reported |
| EDGAR ↗ | SVELTE MEDICAL SYSTEMS INC | Executive Officer, Director | Jun 4, 2013 | D/A | $5,470,329 | $4,307,884 | 7 | No minimum reported |
| EDGAR ↗ | SVELTE MEDICAL SYSTEMS INC | Executive Officer, Director | Apr 29, 2013 | D | $3,000,000 | $1,809,555 | 3 | No minimum reported |
| EDGAR ↗ | eNeura, INC. | Executive Officer, Director | Apr 11, 2013 | D | $2,725,000 | $2,226,421 | 44 | No minimum reported |
| EDGAR ↗ | Avertix Medical, Inc. | Director | Apr 3, 2013 | D/A | $17,535,000 | $17,535,000 | 19 | No minimum reported |
| EDGAR ↗ | GlucoTrack, Inc. | Director | Mar 28, 2013 | D/A | $7,455,399 | $7,455,399 | 89 | No minimum reported |
| EDGAR ↗ | eNeura, INC. | Director | Dec 13, 2012 | D | $3,500,000 | $132,500 | 12 | $10,000 |
| EDGAR ↗ | Avertix Medical, Inc. | Director | Dec 13, 2012 | D | $17,525,000 | $3,762,500 | 17 | No minimum reported |
| EDGAR ↗ | GlucoTrack, Inc. | Director | Dec 3, 2012 | D | $5,500,000 | $1,155,399 | 27 | No minimum reported |
| EDGAR ↗ | eNeura, INC. | Director | Nov 9, 2012 | D | $1,600,000 | $1,000,000 | 16 | No minimum reported |
| EDGAR ↗ | SVELTE MEDICAL SYSTEMS INC | Executive Officer, Director | Jun 21, 2012 | D | $7,000,000 | $5,000,000 | 13 | No minimum reported |
| EDGAR ↗ | SVELTE MEDICAL SYSTEMS INC | Executive Officer, Director | Dec 14, 2011 | D | $35,000,000 | $18,784,666 | 22 | No minimum reported |
| EDGAR ↗ | SVELTE MEDICAL SYSTEMS INC | Executive Officer, Director | Jul 15, 2011 | D/A | $12,000,000 | $9,694,400 | 22 | No minimum reported |
| EDGAR ↗ | Aseko, Inc. | Executive Officer, Director | Jun 9, 2011 | D | $2,000,000 | $2,000,000 | 1 | $2,000,000 |
| EDGAR ↗ | Aseko, Inc. | Executive Officer, Director | May 27, 2011 | D | $462,150 | $462,150 | 1 | $462,150 |
| EDGAR ↗ | MagneMark, LLC group: Magnemark | Director Manager | Jan 20, 2011 | D | $600,000 | $600,000 | 7 | No minimum reported |
| EDGAR ↗ | Aseko, Inc. | Executive Officer, Director | Jan 13, 2011 | D | $100,000 | $100,000 | 5 | $20,000 |
| EDGAR ↗ | GlucoTrack, Inc. | Director | Dec 27, 2010 | D | $12,500,000 | $3,566,047 | 57 | $18,000 |
| EDGAR ↗ | Neuralieve, Inc. | Executive Officer, Director | Dec 10, 2010 | D/A | $15,500,000 | $7,481,174 | 25 | No minimum reported |
| EDGAR ↗ | SVELTE MEDICAL SYSTEMS INC | Executive Officer, Director | Oct 27, 2010 | D | $6,000,000 | $4,492,700 | 14 | No minimum reported |
| EDGAR ↗ | SVELTE MEDICAL SYSTEMS INC | Executive Officer, Director | Mar 16, 2010 | D/A | $10,000,000 | $4,151,043 | 22 | No minimum reported |
| EDGAR ↗ | MagneMark, LLC group: Magnemark | Director Manager | Mar 16, 2010 | D | $45,044 | $45,044 | 6 | No minimum reported |
| EDGAR ↗ | Neuralieve, Inc. | Executive Officer, Director | Jan 11, 2010 | D | $7,500,000 | $3,890,652 | 24 | No minimum reported |
| EDGAR ↗ | SVELTE MEDICAL SYSTEMS INC | Executive Officer, Director | Nov 27, 2009 | D | $9,000,000 | $6,000,000 | 11 | No minimum reported |
| EDGAR ↗ | Aseko, Inc. | Executive Officer, Director | Jul 13, 2009 | D | $9,515,975 | $131,415 | 15 | No minimum reported |
| EDGAR ↗ | SVELTE MEDICAL SYSTEMS INC | Executive Officer, Director | May 28, 2009 | D/A | $8,000,000 | $6,270,000 | 25 | $6,250 |
Every row is a Form D or D/A on which the issuer listed this name as a related person. Related-person names are matched on first + last name and the address state on the filing; records that share a name but could not be tied together by a second identifier are listed separately below.
"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); Other Health Care / 506(b) (4,189 filings); Other Technology / 506(b) (17,390 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
People and management entities the issuers listed as related persons on the same Form D filings as Robert E. Fischell. Source: the EDGAR rows in the table above. Showing the 40 with the most shared filings.
None found in sources searched.
Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.
Export this report as PDF (members · included free during the launch period)
No corrections have been requested for this page.
Free. Logged with status: received → under review → fixed / confirmed with source.
If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.
Members get an email when Robert E. Fischell appears on a new Form D, or when a court case or SEC action is matched to them. See plans →